Strs Ohio Adagio Therapeutics, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	N/A	24,300 New	24,300 $29,000
Q3 2022 Oct 27, 2022	BUY	$2.97 - $4.83 $30,888 - $50,232	10,400 Added 74.82%	24,300 $76,000
Q1 2022 Apr 21, 2022	BUY	$3.81 - $10.77 $34,671 - $98,007	9,100 Added 189.58%	13,900 $63,000
Q3 2021 Oct 22, 2021	BUY	$20.88 - $56.08 $100,224 - $269,184	4,800 New	4,800 $202,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.